Trop-2 cell-surface expression was reported previously in various human tumor lines, including breast (TNBC, HER2+, and HR+), lung (NSCLC and squamous cell), gastric, pancreatic, and colon [26]. Here, ERBB2 is linked to non-small cell lung carcinoma.